Net shares · 365d
-19.8K
0 buy · 19.8K sell
Net value · 365d
-$475.6K
$0 in · $475.6K out
Sentiment · 365d
Net selling
0% buying · 100% selling
Open-market trades · 365d
2
0 buy · 19.8K sell
Trading track record · all companies
Not enough open-market trades to chart a track record yet.
Running net of open-market buys − sells across every company. Tap the line or a marker for details. ▲ buy · ▼ sell.
Transactions · 365d
-
ZYME Sell·S
EVP & Chief Medical Officer
$211.1K
9.3K sh · $22.67
Own -26%
-
ZYME Sell·S
EVP & Chief Medical Officer
$264.5K
10.5K sh · $25.10
Own -36%
| Date▾ | Ticker | Type | Shares | Value |
|---|---|---|---|---|
| Jan 12, 2026 | ZYME | Sell S | 9.3K | $211.1K |
| Jan 5, 2026 | ZYME | Sell S | 10.5K | $264.5K |
Buy Sell Non-market (grant · exercise · gift)
About Smith Jeffrey T L
This profile aggregates every SEC Form 4 insider transaction reported by Smith Jeffrey T L across all companies they trade. Open-market purchases (code P) and sales (code S) are the highest-signal, discretionary trades; grants (A), option exercises (M) and gifts (G) reflect compensation rather than conviction and carry no market price. Figures cover the selected period and update as new filings are ingested.